NCT04928859View on ClinicalTrials.gov

Study on Efficacy and Safety of Human Albumin in Burn Shock Recovery

CompletedOBSERVATIONAL

Enrollment

364

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

January 1, 2019

Study Completion Date

July 30, 2020

Conditions

Burns Shock

Interventions

DRUG

Albumin

"At least one dose of human albumin was used for the patients during hospitalization in the burn ward consisted the albumin group.~The patients who have no albumin use during their hospitalization in the burn ward consisted the control group."

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT04928859 - Study on Efficacy and Safety of Human Albumin in Burn Shock Recovery | Biotech Hunter | Biotech Hunter